BFG
BSX icon

Bleakley Financial Group’s Boston Scientific BSX Stock Holding History

Bleakley Financial Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.16M Buy
74,133
+30,439
+70% +$1.65M 0.04% 354
2026
Q1 		$2.74M Sell
43,694
-45,999
-51% -$3.68M 0.04% 327
2025
Q4 		$8.55M Buy
89,693
+2,301
+3% +$226K 0.15% 112
2025
Q3 		$8.53M Buy
87,392
+7,232
+9% +$749K 0.2% 89
2025
Q2 		$8.61M Buy
80,160
+20,881
+35% +$2.11M 0.22% 86
2025
Q1 		$5.98M Buy
59,279
+6,901
+13% +$695K 0.19% 104
2024
Q4 		$4.68M Buy
52,378
+12,788
+32% +$1.13M 0.14% 125
2024
Q3 		$3.32M Sell
39,590
-245,894
-86% -$19.4M 0.1% 173
2024
Q2 		$22M Sell
285,484
-2,490
-0.9% -$182K 0.63% 25
2024
Q1 		$19.7M Buy
287,974
+16,592
+6% +$1.07M 0.57% 27
2023
Q4 		$15.7M Buy
271,382
+3,010
+1% +$161K 0.5% 38
2023
Q3 		$14.2M Buy
268,372
+6,562
+3% +$344K 0.5% 37
2023
Q2 		$14.2M Buy
261,810
+4,449
+2% +$232K 0.44% 42
2023
Q1 		$12.9M Buy
257,361
+7,461
+3% +$352K 0.43% 43
2022
Q4 		$11.6M Buy
+249,900
New +$10.8M 0.41% 47

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bleakley Financial Group's BSX Position: Q2 2026 in Review

Bleakley Financial Group increased its Boston Scientific (BSX) stake by 70% in Q2 2026, buying an estimated $1.65M and bringing the position to 74,133 shares worth $3.16M. The position accounts for 0.04% of the portfolio, ranked #354.

Bleakley Financial Group first reported a position in BSX in Q4 2022 and has held it in 15 quarters since. The position peaked at $22M in Q2 2024. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bleakley Financial Group held 74,133 shares of Boston Scientific worth $3.16M as of Q2 2026.
  • Bleakley Financial Group bought 30,439 Boston Scientific shares in Q2 2026, an estimated $1.65M.
  • Boston Scientific made up 0.04% of Bleakley Financial Group's portfolio in Q2 2026, its #354 holding.
  • Bleakley Financial Group first reported a position in Boston Scientific in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's Boston Scientific position peaked at $22M in Q2 2024.
  • 1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.